Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts.

Palacios-Moreno J, Foltz L, Guo A, Stokes MP, Kuehn ED, George L, Comb M, Grimes ML.

PLoS Comput Biol. 2015 Apr 17;11(4):e1004130. doi: 10.1371/journal.pcbi.1004130. eCollection 2015 Apr.

2.

Wrangling phosphoproteomic data to elucidate cancer signaling pathways.

Grimes ML, Lee WJ, van der Maaten L, Shannon P.

PLoS One. 2013;8(1):e52884. doi: 10.1371/journal.pone.0052884. Epub 2013 Jan 3.

3.

Nonparametric simulation of signal transduction networks with semi-synchronized update.

Nassiri I, Masoudi-Nejad A, Jalili M, Moeini A.

PLoS One. 2012;7(6):e39643. doi: 10.1371/journal.pone.0039643. Epub 2012 Jun 21.

4.

Predicting cytotoxic T-cell age from multivariate analysis of static and dynamic biomarkers.

Rivet CA, Hill AS, Lu H, Kemp ML.

Mol Cell Proteomics. 2011 Mar;10(3):M110.003921. doi: 10.1074/mcp.M110.003921. Epub 2010 Dec 30.

5.

A mammalian functional-genetic approach to characterizing cancer therapeutics.

Jiang H, Pritchard JR, Williams RT, Lauffenburger DA, Hemann MT.

Nat Chem Biol. 2011 Feb;7(2):92-100. doi: 10.1038/nchembio.503. Epub 2010 Dec 26.

6.

Synthetic lethal screen of an EGFR-centered network to improve targeted therapies.

Astsaturov I, Ratushny V, Sukhanova A, Einarson MB, Bagnyukova T, Zhou Y, Devarajan K, Silverman JS, Tikhmyanova N, Skobeleva N, Pecherskaya A, Nasto RE, Sharma C, Jablonski SA, Serebriiskii IG, Weiner LM, Golemis EA.

Sci Signal. 2010 Sep 21;3(140):ra67. doi: 10.1126/scisignal.2001083.

7.

Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Zhang J, Chen YH, Lu Q.

Future Oncol. 2010 Apr;6(4):587-603. doi: 10.2217/fon.10.15. Review.

Items per page

Supplemental Content

Write to the Help Desk